hiv-infection/aids

Search with Google Search with Bing
Information
Disease name
hiv-infection/aids
Disease ID
Description
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
UGT1A3 2 233,729,042 233,773,300 4
UGT1A8 2 233,617,633 233,773,300 4
UGT1A10 2 233,636,448 233,773,300 4
UGT1A5 2 233,712,907 233,773,300 4
UGT1A6 2 233,692,890 233,773,300 4
UGT1A9 2 233,671,898 233,773,300 4
UGT1A7 2 233,681,901 233,773,300 4
UGT1A4 2 233,718,736 233,773,300 4
UGT1A1 2 233,760,270 233,773,300 2
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03403569 Completed Phase 3 Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection September 1, 2018 June 30, 2021
NCT04371835 Completed COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings August 12, 2020 December 31, 2021
NCT01360762 Completed Phase 3 Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study November 2011 November 2015
NCT01406626 Completed N/A Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care December 2012 October 2016
NCT00787696 Completed Phase 1/Phase 2 Healthy Teen Girls: HIV Risk Reduction September 2003 December 2009
NCT01475890 Completed Phase 2/Phase 3 Vitamin D Supplementation in HIV July 2011 February 2017
NCT01827540 Completed Phase 1 Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam March 2013 May 2013
NCT02433743 Completed N/A Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA October 2011 July 2012
NCT02496793 Completed N/A Community-Based Peer Facilitator Intervention (Zimbabwe) January 2012 June 2013
NCT03794648 Completed N/A The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication February 13, 2018 December 31, 2018
NCT03069235 Completed N/A Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program February 8, 2012 November 30, 2013
NCT01140633 Completed Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda April 2010 August 2012
NCT04373551 Enrolling by invitation N/A WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP) April 14, 2020 August 30, 2025
NCT05947539 Recruiting N/A Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention July 1, 2023 August 2025
NCT03147859 Recruiting Phase 2 Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection November 1, 2017 December 31, 2023
NCT04297488 Recruiting N/A Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection May 1, 2020 July 1, 2025
NCT04215926 Unknown status NAFLD in HIV-infected Patients December 5, 2019 November 30, 2020
NCT04303598 Unknown status Phase 3 Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients April 1, 2020 August 1, 2022
NCT03919695 Unknown status N/A Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda December 7, 2020 July 2022
NCT02753049 Unknown status N/A Adherence Connection for Counseling, Education, and Support November 23, 2016 August 2018
NCT01442428 Withdrawn Phase 2/Phase 3 Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial January 2014 June 2016
NCT04183738 Withdrawn Phase 4 Inflammation and Co-Infections in D²EFT February 1, 2021 December 19, 2022